- Home
- WSR vs LXRX Comparison
WSR vs LXRX Comparison
Compare WSR & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSR
- LXRX
- Stock Information
- Founded
- WSR 1998
- LXRX 1995
- Country
- WSR United States
- LXRX United States
- Employees
- WSR N/A
- LXRX N/A
- Industry
- WSR Real Estate Investment Trusts
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- WSR Real Estate
- LXRX Health Care
- Exchange
- WSR Nasdaq
- LXRX Nasdaq
- Market Cap
- WSR 676.5M
- LXRX 541.5M
- IPO Year
- WSR 2010
- LXRX 2000
- Fundamental
- Price
- WSR $13.48
- LXRX $1.39
- Analyst Decision
- WSR Strong Buy
- LXRX Buy
- Analyst Count
- WSR 2
- LXRX 5
- Target Price
- WSR $15.50
- LXRX $3.23
- AVG Volume (30 Days)
- WSR 248.2K
- LXRX 2.3M
- Earning Date
- WSR 10-29-2025
- LXRX 11-06-2025
- Dividend Yield
- WSR 4.00%
- LXRX N/A
- EPS Growth
- WSR 108.75
- LXRX N/A
- EPS
- WSR 0.86
- LXRX N/A
- Revenue
- WSR $157,788,000.00
- LXRX $70,864,000.00
- Revenue This Year
- WSR $2.83
- LXRX $66.55
- Revenue Next Year
- WSR $5.98
- LXRX N/A
- P/E Ratio
- WSR $15.73
- LXRX N/A
- Revenue Growth
- WSR 5.59
- LXRX 1255.21
- 52 Week Low
- WSR $11.43
- LXRX $0.28
- 52 Week High
- WSR $15.36
- LXRX $1.66
- Technical
- Relative Strength Index (RSI)
- WSR 61.65
- LXRX 49.96
- Support Level
- WSR $12.93
- LXRX $1.28
- Resistance Level
- WSR $13.48
- LXRX $1.52
- Average True Range (ATR)
- WSR 0.24
- LXRX 0.13
- MACD
- WSR -0.01
- LXRX -0.01
- Stochastic Oscillator
- WSR 72.66
- LXRX 48.91
About WSR Whitestone REIT
Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in metropolitan areas. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business friendly locations in and around Austin, Chicago, Dallas-Fort Worth, Houston, Phoenix, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.